Latest treatment news and information for patient advocates and people working in hepatitis in Europe. Find out more about infohep >

NAM working with the World Hepatitis Alliance and the European Liver Patients Association

   
Markus Cornberg presenting at The International Liver Congress. Image: EASL Education @EASLeduMarkus Cornberg presenting at The International Liver Congress. Image: EASL Education @EASLedu

EASL 2019: Pangenotypic regimens

Pangenotypic hepatitis C drug combinations curing almost all people who complete treatment, real-world studies show.

ELPA board member Gamal Shiha presenting the Egyptian pilot study at The International Liver Congress. Image: ELPA @HepatitisEuropeELPA board member Gamal Shiha presenting the Egyptian pilot study at The International Liver Congress. Image: ELPA @HepatitisEurope

EASL 2019: Hepatitis C screening policies

Same-day hepatitis C treatment initiation can be achieved at large scale, Egyptian pilot study shows.

Margaret Hellard presenting at The International Liver Congress. Image: @AnnetteGaudino and @TAGTeam_TweetsMargaret Hellard presenting at The International Liver Congress. Image: @AnnetteGaudino and @TAGTeam_Tweets

EASL 2019: Finance and funding

$51 billion price tag for eliminating hepatitis C by 2030.

Hepatitis bulletin

Hepatitis bulletin

Sign up for our free monthly hepatitis news bulletin.

infohep news

Latest library resources

Looking for country specific news, resources and services?

Looking for country specific news, resources and services?

Visit our country information pages >

Keep up to date with the latest hepatitis news

Keep up to date with the latest hepatitis news

Sign up for our free monthly email bulletin >